CytoMed Therapeutics
GDTC
#9863
Rank
$26.08 M
Marketcap
$2.26
Share price
-8.87%
Change (1 day)
7.11%
Change (1 year)

CytoMed Therapeutics (GDTC) - P/B ratio

P/B ratio as of April 2025 : 3.06

According to CytoMed Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

CytoMed Therapeutics - P/B ratio (from 2023 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-316.64
2022-12-31N/A
2021-12-31N/A